GO:0032817 regulation of natural killer cell proliferation: Immune Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032817 describes any process that modulates the frequency, rate, or extent of natural killer (NK) cell proliferation.
• NK cell homeostasis depends on a balance of proliferation, survival, and maturation signals, and its dysregulation contributes to immune deficiency and cancer.
• T cells and other immune cells can regulate NK cell proliferation through cytokine-dependent and contact-dependent mechanisms.
• Transcription factors such as c-Myb directly influence NK cell activity and proliferation-associated programs.
• Tumor microenvironment components, including lipid-laden mesenchymal cells, can metabolically reprogram NK cells and suppress their proliferation.
• NK cell-related gene signatures are being developed as diagnostic and prognostic tools in breast cancer, highlighting the clinical relevance of this process.
Description
Natural killer (NK) cells are innate lymphoid cells that provide rapid defense against virally infected and transformed cells. The process of NK cell proliferation must be tightly regulated to maintain adequate cell numbers for immune surveillance while preventing excessive or autoimmune responses. GO:0032817, regulation of natural killer cell proliferation, captures the biological processes that control the frequency, rate, or extent of NK cell division. Understanding this regulation is essential because NK cell homeostasis is disrupted in multiple pathological states, including cancer, chronic infections, and immune deficiencies. Recent studies have shown that NK cell proliferation is influenced by a complex network of cytokines, transcription factors, and cellular interactions. For example, T cells can regulate NK cell responses through both soluble mediators and direct contact, shaping the proliferative capacity of NK cells. Moreover, the tumor microenvironment can metabolically reprogram NK cells, impairing their proliferation and effector functions. These findings underscore the importance of GO:0032817 in both basic immunology and translational research. This article provides a research-grade overview of the definition, mechanisms, key genes, disease links, and experimental models relevant to the regulation of NK cell proliferation.
regulation of natural killer cell proliferation At A Glance
| GO ID | GO:0032817 |
|---|---|
| GO term | regulation of natural killer cell proliferation |
| Ontology | biological_process |
| Synonym | regulation of NK cell proliferation |
| Definition | Any process that modulates the frequency, rate or extent of natural killer cell proliferation. |
| Major function | Controls NK cell numbers and immune surveillance capacity. |
| Related cell type | Natural killer (NK) cells |
| Associated processes | Cytokine signaling, transcription factor activity, cell cycle regulation. |
| Disease relevance | Cancer, chronic infections, autoimmune disorders. |
What Is GO:0032817?
According to the Gene Ontology, GO:0032817 (regulation of natural killer cell proliferation) is defined as any process that modulates the frequency, rate, or extent of natural killer cell proliferation. In other words, it encompasses all molecular and cellular events that control how often NK cells divide and how many new NK cells are produced. This regulation can be positive (promoting proliferation) or negative (inhibiting proliferation) and involves signals from cytokines, growth factors, cell surface receptors, and intracellular signaling pathways.
Why Is regulation of natural killer cell proliferation Important in Cell Biology?
Regulation of NK cell proliferation is critical for maintaining a functional immune system. NK cells are key effectors of innate immunity, and their numbers must be sufficient to eliminate pathogens and tumor cells. However, uncontrolled proliferation can lead to immune pathology. Therefore, understanding GO:0032817 provides insights into how the immune system balances NK cell production and prevents disease. This knowledge is particularly relevant for cancer immunotherapy, where NK cell expansion is often desired, and for autoimmune diseases, where excessive NK cell activity may contribute to tissue damage.
• Maintains adequate NK cell numbers for immune surveillance against tumors and viruses.
• Dysregulation can lead to immune deficiency or autoimmunity.
• NK cell proliferation is a key determinant of responses to immunotherapy.
• T cells and other immune cells modulate NK cell proliferation, influencing overall immune responses.
• Transcription factors like c-Myb directly regulate NK cell activity and proliferation.
• Tumor microenvironment factors, such as lipid-laden mesenchymal cells, can suppress NK cell proliferation.
• NK cell-related gene signatures have diagnostic and prognostic value in breast cancer.
• Understanding this process aids in developing methods to produce clinical-scale NK cells from pluripotent stem cells.
• Bone marrow NK cells can inhibit T cell proliferation, illustrating bidirectional regulation.
• Senescent cells in the liver limit fibrosis through NK cell-mediated mechanisms, linking proliferation regulation to tissue remodeling.
What Happens During regulation of natural killer cell proliferation?
Initiation by Cytokine Signals
In simple terms: Cytokines are chemical messengers that tell NK cells to start dividing.
NK cell proliferation is initiated by cytokines such as interleukin-2 (IL-2), IL-15, and IL-21, which bind to receptors on the NK cell surface and trigger intracellular signaling cascades. These signals activate transcription factors that drive cell cycle entry. The availability of these cytokines is tightly controlled by other immune cells, including T cells, which can produce or consume them.
Transcription Factor Activation
In simple terms: Transcription factors are proteins that turn genes on or off to control cell division.
Upon cytokine stimulation, transcription factors such as c-Myb are activated or upregulated. c-Myb plays a critical role in regulating NK cell activity and proliferation by controlling the expression of genes involved in cell cycle progression and survival. Other transcription factors, including T-bet and Eomes, also contribute to NK cell maturation and proliferation, although their specific roles in GO:0032817 are still being defined.
Cell Cycle Progression
In simple terms: The cell cycle is the series of steps a cell goes through to divide into two new cells.
Once activated, NK cells enter the cell cycle, progressing through G1, S, G2, and M phases. This progression is regulated by cyclins, cyclin-dependent kinases (CDKs), and their inhibitors. The rate of proliferation is determined by the balance between positive and negative regulators of the cell cycle. Dysregulation of these checkpoints can lead to excessive or insufficient NK cell numbers.
Metabolic Reprogramming
In simple terms: Cells need energy and building blocks to divide, so they change their metabolism.
Proliferating NK cells undergo metabolic reprogramming to meet the demands of rapid division. This includes increased glycolysis and glutaminolysis. The tumor microenvironment can disrupt this metabolic reprogramming; for example, lipid-laden lung mesenchymal cells foster breast cancer metastasis by metabolically reprogramming NK cells, thereby suppressing their proliferation and function.
Regulation by Other Immune Cells
In simple terms: Other immune cells can either help or stop NK cells from dividing.
T cells can regulate NK cell proliferation through direct cell contact and secreted factors. For instance, regulatory T cells can suppress NK cell proliferation, while conventional T cells can enhance it via cytokine production. Additionally, bone marrow NK cells have been shown to inhibit T cell proliferation, indicating a bidirectional regulatory network.
Termination and Homeostasis
In simple terms: After an immune response, NK cell numbers return to normal to prevent damage.
Once the threat is cleared, NK cell proliferation must be terminated to restore homeostasis. This involves negative feedback mechanisms, including cytokine withdrawal, upregulation of inhibitory receptors, and apoptosis of excess NK cells. Senescent cells can also influence NK cell proliferation; for example, senescence of activated stellate cells limits liver fibrosis through NK cell-mediated clearance.
Key Genes Involved in GO:0032817 regulation of natural killer cell proliferation
The following genes and proteins have been experimentally linked to the regulation of NK cell proliferation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL2 | Cytokine that promotes NK cell proliferation and activation. | Used in NK cell expansion protocols for immunotherapy. |
| IL15 | Critical cytokine for NK cell development, survival, and proliferation. | Key factor in NK cell homeostasis and memory-like NK cell generation. |
| MYB | Transcription factor regulating NK cell activity and proliferation. | Potential target for modulating NK cell responses. |
| TBX21 | Transcription factor T-bet controlling NK cell maturation and function. | Marker of NK cell subsets with distinct proliferative capacities. |
| EOMES | Transcription factor Eomesodermin regulating NK cell development. | Cooperates with T-bet in NK cell maturation. |
| KLRD1 | CD94, part of NKG2 receptors, modulates NK cell activation. | Influences NK cell proliferation via inhibitory signaling. |
| NCR1 | NKp46, activating receptor on NK cells. | Marker of NK cells; signaling can affect proliferation. |
| FCGR3A | CD16, mediates antibody-dependent cellular cytotoxicity. | Expressed on mature NK cells; proliferation linked to maturation stage. |
| GZMB | Granzyme B, effector molecule in NK cell cytotoxicity. | Indicates active NK cells; proliferation often accompanies cytotoxic potential. |
| PRF1 | Perforin, pore-forming protein in NK cell granules. | Defects cause immune dysregulation; proliferation may be compensatory. |
| IFNG | Interferon-gamma, cytokine produced by NK cells. | Autocrine regulation of NK cell proliferation and activation. |
| CCL5 | Chemokine involved in NK cell recruitment. | May indirectly influence proliferation by recruiting NK cells to sites. |
| STAT5A | Signal transducer downstream of IL-2/IL-15 receptors. | Essential for NK cell proliferation and survival. |
| STAT5B | Signal transducer downstream of cytokine receptors. | Mutations affect NK cell homeostasis. |
| MTOR | Kinase integrating nutrient and growth signals. | Regulates NK cell metabolism and proliferation. |
| HIF1A | Hypoxia-inducible factor, metabolic regulator. | Influences NK cell function in tumor microenvironment. |
| B3GNT2 | Glycosyltransferase affecting receptor signaling. | May modulate NK cell proliferation via surface receptors. |
| NKG7 | Granule membrane protein in NK cells. | Associated with NK cell cytotoxic activity and proliferation signatures. |
How Is regulation of natural killer cell proliferation Regulated?
The regulation of NK cell proliferation is a complex process involving multiple layers of control. Cytokine signaling through IL-2 and IL-15 receptors activates JAK-STAT pathways, particularly STAT5, which drives expression of proliferation-associated genes. Transcription factors such as c-Myb further modulate the proliferative program. Metabolic pathways, including mTOR signaling, integrate nutrient availability with proliferation signals, and their dysregulation in the tumor microenvironment can suppress NK cell proliferation. Additionally, interactions with other immune cells, such as T cells, provide extrinsic regulatory cues. Negative feedback mechanisms, including inhibitory receptor engagement and apoptosis, prevent excessive NK cell expansion.
regulation of natural killer cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL15 | Cancer immunotherapy; NK cell expansion | IL15 knockout or transgenic mice; human NK cell culture. |
| MYB | Leukemia; NK cell deficiency | Conditional Myb knockout mice; NK cell-specific deletion. |
| MTOR | Metabolic disorders; tumor microenvironment | mTOR inhibitor treatment in NK cells; metabolic assays. |
| STAT5B | Immune dysregulation; NK cell homeostasis | STAT5B knockout or point mutation models. |
| NKG7 | Breast cancer prognosis | NKG7 knockout NK cell lines; xenograft models. |
Cancer
NK cells play a critical role in tumor immunosurveillance, and their proliferation is often suppressed in the tumor microenvironment. Lipid-laden lung mesenchymal cells foster breast cancer metastasis by metabolically reprogramming NK cells, leading to reduced proliferation and impaired effector function. NK cell-related gene signatures have been developed as diagnostic and prognostic tools in breast cancer, underscoring the clinical importance of NK cell proliferation regulation.
Chronic Infections
Persistent viral infections can lead to NK cell exhaustion, characterized by reduced proliferative capacity and impaired cytotoxicity. The regulation of NK cell proliferation is therefore crucial for maintaining effective antiviral immunity.
Autoimmune and Inflammatory Diseases
Dysregulated NK cell proliferation can contribute to autoimmune pathology. For example, bone marrow NK cells can inhibit T cell proliferation, and disruption of this regulatory axis may exacerbate autoimmune responses. Additionally, senescent cells in the liver limit fibrosis through NK cell-mediated mechanisms, linking NK cell proliferation regulation to tissue remodeling and chronic inflammation.
From regulation of natural killer cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate NK cell proliferation? | CRISPR knockout of gene X in primary human NK cells or NK cell lines (e.g., NK-92). |
| Does a specific point mutation in gene Y affect NK cell proliferation? | CRISPR point mutation knock-in in induced pluripotent stem cells (iPSCs) differentiated into NK cells. |
| What is the effect of overexpressing gene Z on NK cell expansion? | Lentiviral overexpression of gene Z in NK cells followed by proliferation assays. |
| How does a tagged version of protein W localize during NK cell proliferation? | CRISPR knock-in of a fluorescent tag (e.g., GFP) at the endogenous locus. |
| Which genes are essential for NK cell proliferation? | Genome-wide CRISPR library screening in NK cell lines. |
| How do T cells regulate NK cell proliferation? | Co-culture of T cells and NK cells with or without transwell separation. |
How to Study the regulation of natural killer cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CFSE dilution | Cell division history | Tracking NK cell proliferation in vitro and in vivo. |
| Ki-67 staining | Active cell cycle entry | Quantifying proliferating NK cells in tissues. |
| CRISPR knockout screening | Gene essentiality for proliferation | Identifying novel regulators of NK cell proliferation. |
| RNA-seq | Transcriptional changes | Comparing proliferating vs. quiescent NK cells. |
| Seahorse assay | Glycolysis and oxidative phosphorylation | Assessing metabolic reprogramming during proliferation. |
| Co-culture assays | Cell-cell regulation | Studying T cell-mediated regulation of NK cell proliferation. |
| Phospho-flow | Signaling pathway activation | Measuring STAT5 phosphorylation in response to cytokines. |
| In vivo adoptive transfer | NK cell expansion in vivo | Evaluating NK cell proliferation in mouse models. |
Flow Cytometry
Flow cytometry is the gold standard for measuring NK cell proliferation, typically using carboxyfluorescein succinimidyl ester (CFSE) dilution or Ki-67 staining. It allows simultaneous assessment of surface markers and proliferation status.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens in NK cell lines can identify genes that regulate proliferation under various conditions. These screens are powerful for discovering novel regulators of GO:0032817.
RNA Sequencing
RNA-seq of proliferating versus quiescent NK cells reveals transcriptional programs underlying proliferation. It can identify differentially expressed genes and pathways, such as cytokine signaling and cell cycle regulators.
Metabolic Assays
Seahorse extracellular flux analysis and metabolomics measure metabolic changes during NK cell proliferation. These methods are useful for studying how the tumor microenvironment affects NK cell metabolism and proliferation.
How CRISPR Can Be Used to Study GO:0032817 regulation of natural killer cell proliferation
Knockout
CRISPR knockout of candidate genes in NK cells or NK cell lines can determine whether a gene is required for proliferation. For example, knocking out MYB or STAT5B would test their essential roles in NK cell proliferation.
Point Mutation
CRISPR point mutation knock-in can model specific human variants associated with NK cell disorders. This approach allows precise interrogation of how a single amino acid change affects NK cell proliferation.
Knock-in
Knock-in of reporter genes (e.g., fluorescent proteins) or epitope tags at endogenous loci enables live tracking of NK cell proliferation and protein localization. This is particularly useful for studying dynamic processes.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive high expression of a gene of interest to test whether it is sufficient to enhance NK cell proliferation. This is valuable for identifying positive regulators.
How EDITGENE Supports regulation of natural killer cell proliferation Research
Researchers studying regulation of natural killer cell proliferation-related genes often need to determine whether a candidate gene is causally involved in NK cell expansion, whether a specific mutation alters function, or how a gene product localizes during proliferation. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of natural killer cell proliferation research.
Frequently Asked Questions About regulation of natural killer cell proliferation
What is GO:0032817?
GO:0032817 is the Gene Ontology term for regulation of natural killer cell proliferation, defined as any process that modulates the frequency, rate, or extent of NK cell proliferation.
What genes are involved in regulation of natural killer cell proliferation?
Key genes include IL2, IL15, MYB, STAT5A, STAT5B, MTOR, and TBX21, among others.
How is NK cell proliferation measured?
NK cell proliferation is commonly measured by flow cytometry using CFSE dilution or Ki-67 staining.
What diseases are associated with dysregulated NK cell proliferation?
Dysregulation is linked to cancer, chronic infections, and autoimmune diseases.
Can CRISPR be used to study NK cell proliferation?
Yes, CRISPR knockout, knock-in, and activation screens are powerful tools to study genes regulating NK cell proliferation.
What is the role of T cells in NK cell proliferation?
T cells can regulate NK cell proliferation through cytokines and direct contact, either enhancing or suppressing it.
How does the tumor microenvironment affect NK cell proliferation?
The tumor microenvironment can metabolically reprogram NK cells, leading to suppressed proliferation and impaired function.
What transcription factors regulate NK cell proliferation?
c-Myb is a key transcription factor regulating NK cell activity and proliferation; T-bet and Eomes also play roles.
What methods are used to study regulation of NK cell proliferation?
Flow cytometry, RNA-seq, CRISPR screens, and metabolic assays are commonly used.
Why is regulation of NK cell proliferation important for immunotherapy?
Understanding this process helps optimize NK cell expansion for cancer immunotherapy and identify strategies to overcome tumor-induced suppression.
Conclusion
GO:0032817, regulation of natural killer cell proliferation, is a fundamental biological process that ensures adequate NK cell numbers for immune defense while preventing pathological overexpansion. Its dysregulation contributes to cancer, chronic infections, and autoimmune diseases. Recent advances in CRISPR technology and functional genomics have accelerated the discovery of genes and pathways controlling NK cell proliferation. Continued research in this area promises to improve NK cell-based immunotherapies and provide new therapeutic targets for immune-related disorders.
References
- 1. Pfefferle A et al.. 2020. Deciphering Natural Killer Cell Homeostasis.. Front Immunol 11:812 PMID: 32477340
- 2. Gong Z et al.. 2022. Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells.. Cell Metab 34(12):1960-1976.e9 PMID: 36476935
- 3. Fang Y et al.. 2025. Machine learning-based diagnostic and prognostic models for breast cancer: a new frontier on the clinical application of natural killer cell-related gene signatures in precision medicine.. Front Immunol 16:1581982 PMID: 40496857
- 4. Krizhanovsky V et al.. 2008. Senescence of activated stellate cells limits liver fibrosis.. Cell 134(4):657-67 PMID: 18724938
- 5. Kerdiles Y et al.. 2013. T cell regulation of natural killer cells.. J Exp Med 210(6):1065-8 PMID: 23733834
- 6. Shin HW et al.. 2018. Role of c-Myb in the regulation of natural killer cell activity.. Biochem Biophys Res Commun 503(4):2807-2813 PMID: 30103947
- 7. Zhu H et al.. 2019. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.. Methods Mol Biol 2048:107-119 PMID: 31396935
- 8. Trivedi PP et al.. 2007. Regulation of adaptive immunity by cells of the innate immune system: bone marrow natural killer cells inhibit T cell proliferation.. Adv Exp Med Biol 590:113-20 PMID: 17191381
